Acorda Therapeutics, Inc. (ACOR) Stock Analysis
DELISTED 2024
What happened to Acorda Therapeutics, Inc. (ACOR) stock?
Acorda Therapeutics, Inc. (ACOR) no longer trades on public markets. It was delisted in May 2024. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- May 2024
- Last recorded price (historical):
- $0.661 (last quote on record before the May 2024 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Acorda Therapeutics, Inc. (ACOR). Acorda Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing therapies for neurological disorders.
Last analyzed: Mar 16, 2026Acorda Therapeutics, Inc. (ACOR) Healthcare & Pipeline Overview
More about this archive record
Can I still buy ACOR shares?
No. ACOR stopped trading on public markets in May 2024, so the shares are not available through a broker. Anything you see quoted for ACOR elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ACOR stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Acorda Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.